DK1034171T3 - Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid - Google Patents

Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid

Info

Publication number
DK1034171T3
DK1034171T3 DK98956725T DK98956725T DK1034171T3 DK 1034171 T3 DK1034171 T3 DK 1034171T3 DK 98956725 T DK98956725 T DK 98956725T DK 98956725 T DK98956725 T DK 98956725T DK 1034171 T3 DK1034171 T3 DK 1034171T3
Authority
DK
Denmark
Prior art keywords
piperazinyl
fluorophenyl
ethoxy
bis
methyl
Prior art date
Application number
DK98956725T
Other languages
Danish (da)
English (en)
Inventor
Monique Berwaer
Guy Bodson
Michel Deleers
Charles Dogimont
Domenico Fanara
Jacques Timmermans
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of DK1034171T3 publication Critical patent/DK1034171T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK98956725T 1997-11-26 1998-11-26 Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid DK1034171T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
PCT/BE1998/000184 WO1999028310A1 (en) 1997-11-26 1998-11-26 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride

Publications (1)

Publication Number Publication Date
DK1034171T3 true DK1034171T3 (da) 2001-11-05

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956725T DK1034171T3 (da) 1997-11-26 1998-11-26 Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid

Country Status (39)

Country Link
US (2) US6262057B1 (cs)
EP (2) EP0919550A1 (cs)
JP (2) JP3996348B2 (cs)
KR (1) KR100557711B1 (cs)
CN (1) CN100406448C (cs)
AR (1) AR017676A1 (cs)
AT (1) ATE203237T1 (cs)
AU (1) AU735819B2 (cs)
BG (1) BG64155B1 (cs)
BR (1) BR9815405A (cs)
CA (1) CA2310318C (cs)
CO (1) CO4980892A1 (cs)
CZ (1) CZ295972B6 (cs)
DE (1) DE69801163T2 (cs)
DK (1) DK1034171T3 (cs)
EG (1) EG23776A (cs)
ES (1) ES2161552T3 (cs)
GC (1) GC0000094A (cs)
GR (1) GR3036702T3 (cs)
HU (1) HUP0100343A3 (cs)
ID (1) ID24964A (cs)
IL (1) IL135544A (cs)
MA (1) MA26569A1 (cs)
MY (1) MY119653A (cs)
NO (1) NO314692B1 (cs)
NZ (1) NZ504461A (cs)
PE (1) PE134899A1 (cs)
PL (1) PL190871B1 (cs)
PT (1) PT1034171E (cs)
RS (1) RS49904B (cs)
RU (1) RU2182575C2 (cs)
SI (1) SI20325A (cs)
SK (1) SK283237B6 (cs)
TN (1) TNSN98214A1 (cs)
TR (1) TR200001505T2 (cs)
TW (1) TWI225053B (cs)
UA (1) UA54568C2 (cs)
WO (1) WO1999028310A1 (cs)
ZA (1) ZA9810780B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
EP1414460A1 (en) * 2001-07-26 2004-05-06 Ucb, S.A. Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
CA2489865C (en) 2002-06-25 2012-05-08 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
EP1633359A1 (en) * 2003-05-28 2006-03-15 Ucb Farchim S.A. Use of efletirizine for treating persistent allergic rhinitis
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
UA8337A1 (uk) * 1981-02-06 1996-03-29 Бальтес Ежен 2-[4-(дифенілметіл)-1-піперазиніл]-оцтові кислоти або їх аміди, або їх нетоксичні фармацевтично прийняті солі, що проявляють спазмолітичну і антигістамінну активність
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.

Also Published As

Publication number Publication date
NO314692B1 (no) 2003-05-05
PE134899A1 (es) 2000-01-11
EG23776A (en) 2007-08-08
SK5942000A3 (en) 2000-10-09
AU735819B2 (en) 2001-07-19
JP2007224042A (ja) 2007-09-06
ATE203237T1 (de) 2001-08-15
UA54568C2 (uk) 2003-03-17
CA2310318C (en) 2003-10-21
US20010021712A1 (en) 2001-09-13
RU2182575C2 (ru) 2002-05-20
BG64155B1 (bg) 2004-02-27
PL190871B1 (pl) 2006-02-28
SI20325A (sl) 2001-02-28
IL135544A0 (en) 2001-05-20
GC0000094A (en) 2005-06-29
ES2161552T3 (es) 2001-12-01
HUP0100343A3 (en) 2001-09-28
EP0919550A1 (en) 1999-06-02
KR20010032420A (ko) 2001-04-16
KR100557711B1 (ko) 2006-03-07
JP2001524548A (ja) 2001-12-04
US6262057B1 (en) 2001-07-17
TR200001505T2 (tr) 2000-09-21
RS49904B (sr) 2008-08-07
HUP0100343A2 (hu) 2001-07-30
SK283237B6 (sk) 2003-04-01
YU31600A (sh) 2002-03-18
EP1034171A1 (en) 2000-09-13
BR9815405A (pt) 2000-10-10
NO20002631D0 (no) 2000-05-23
ID24964A (id) 2000-08-31
IL135544A (en) 2004-02-08
EP1034171B1 (en) 2001-07-18
TWI225053B (en) 2004-12-11
BG104424A (en) 2001-01-31
JP3996348B2 (ja) 2007-10-24
DE69801163T2 (de) 2002-03-28
CZ295972B6 (cs) 2005-12-14
CA2310318A1 (en) 1999-06-10
CZ20001787A3 (cs) 2000-09-13
CN1279676A (zh) 2001-01-10
CO4980892A1 (es) 2000-11-27
NZ504461A (en) 2001-06-29
NO20002631L (no) 2000-05-23
PT1034171E (pt) 2001-11-30
AR017676A1 (es) 2001-09-12
MY119653A (en) 2005-06-30
DE69801163D1 (en) 2001-08-23
CN100406448C (zh) 2008-07-30
ZA9810780B (en) 1999-05-31
TNSN98214A1 (fr) 2005-03-15
AU1327799A (en) 1999-06-16
GR3036702T3 (en) 2001-12-31
WO1999028310A1 (en) 1999-06-10
MA26569A1 (fr) 2004-12-20
PL340724A1 (en) 2001-02-26
US6335331B2 (en) 2002-01-01

Similar Documents

Publication Publication Date Title
EE05531B1 (et) Tert-butl-(E)-(6-{2-[4-(4-fluorofenl)-6-isopropl-2-[metl(metlsulfonl)amino]primidiin-5-l]vinl}(4R, 6S)-2,2-dimetl[1,3]dioksaan-4-l)atsetaadi valmistamismeetod
NO20005673L (no) Heterocykliske inhibitorer av P38
NO174421C (no) Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelsen 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)-dibenzo(b,f)(1,4)tiazepin
DK1216239T3 (da) Antagonister af piperazin-derivater AS 5-HT1B
NO20100667L (no) Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater
DK1034171T3 (da) Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid
DK0927173T3 (da) Substituerede [2-(1-piperazinyl)ethoxy]methylforbindelser
BR9609849A (pt) Derivados de 2-(4-substituída)-benzilamino-2-metila-propanamid a
AR028281A1 (es) Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona
IL128505A (en) Process for the preparation of (e)-methyl 2-[2-(6-chloropyrimidin-4-yloxy) phenyl]-3-methoxypropenoate
DE69837977D1 (de) Herstellungsverfahren von integrierten optischen Schaltungen zur Minimierung der optischen Kopplungsverluste
FI973164A0 (fi) Antipsykoottisia 4-(1H-indolyl-1-yyli)-1-substituoituja piperidiinijohdannaisia
NO995938D0 (no) Blanding omfattende 5-[4-[2-(N-metyl-N-2-pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
DK1055658T3 (da) Fremstilling af cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphtalen-1-yl)phenoxy]ethyl-pyrrolidin
FI20001721L (fi) 6-hydroksi-3-(4-(/2-(piperidin-1-yyli)etoksi)fenoksi)-2-(4-metoksifenyyli)bentso(b)tiofeenihydrokloridin uusin kiteinen muoto
NO20004664D0 (no) FremgangsmÕte for fremstilling av HIV proteaseinhibitorer
EE05609B1 (et) Dibensotiasepiiniderivaatide valmistamismeetod
NO992268D0 (no) N-bundne sulfonamider av heterocykliske tioestere
DK0983237T3 (da) Kemisk fremgangsmåde til reduktion af 1-substituerede 3-hydroxymethyl-4-(4-fluorphenyl)tetrahydro-pyridiner
ATE525362T1 (de) 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-
BR9603916A (pt) Derivados de ácido 2-(pirazolióxi-pirimidin-5-il) acético
NO995841D0 (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2-fenylpropionsyre-derivater
ID27591A (id) Proses pembuatan isoprop l-metil-[2-(3-n-propoksi-fenoksi) etil] amina
DK1202967T3 (da) Svovlsyre-mono- [3- ({12- (4-fluorphenyl)ethyl]-piperidin-4-yl}hydrowymethyl)-2-methoxyphenylester
SE0003265D0 (sv) Registrering av preferenser